“…Due to variable conditions that can influence poultry susceptibility to infections (20)(21), further investigation was carried out to understand the impact of chIFITM3 against a pre-determined clinical dose of H5N1. The results revealed that the clinical dose of H5N1 considerably reduced the clinical outcome when used in transgeneoverexpressing chicks, which indicates the ability of innate immunity to protect against HPAIV H5N1.…”